"58160-896-52" National Drug Code (NDC)

Fluarix Quadrivalent 10 SYRINGE in 1 CARTON (58160-896-52) > .5 mL in 1 SYRINGE (58160-896-41)
(GlaxoSmithKline Biologicals SA)

NDC Code58160-896-52
Package Description10 SYRINGE in 1 CARTON (58160-896-52) > .5 mL in 1 SYRINGE (58160-896-41)
Product NDC58160-896
Product Type NameVACCINE
Proprietary NameFluarix Quadrivalent
Proprietary Name Suffix2019/2020
Non-Proprietary NameInfluenza Virus Vaccine
Dosage FormSUSPENSION
UsageINTRAMUSCULAR
Start Marketing Date20190702
End Marketing Date20200630
Marketing Category NameBLA
Application NumberBLA125127
ManufacturerGlaxoSmithKline Biologicals SA
Substance NameINFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)
Strength15; 15; 15; 15
Strength Unitug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/58160-896-52